Evidence map›Paper›PMID 26377395›Full record

ArticleBMC pulmonary medicine2015

The utility of Xpert MTB/RIF performed on bronchial washings obtained in patients with suspected pulmonary tuberculosis in a high prevalence setting.

Dewald A Barnard, Elvis M Irusen, Johannes W Bruwer, Danté Plekker, Andrew C Whitelaw, Jacobus D Deetlefs, Coenraad F N Koegelenberg

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC pulmonary medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review and Updates on the Diagnosis of Tuberculosis.Journal of clinical medicine · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Role of Xpert MTB/RIF in Bronchoalveolar lavage fluid of sputum-scarce, suspected Pulmonary TB patients.Journal of clinical tuberculosis and other mycobacterial diseases · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Evaluation of XpertLung India : official organ of Indian Chest Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dewald A BarnardDivisions of Pulmonology, Department of Medicine, Stellenbosch University, PO Box 19063, 7505, Cape Town, South Africa. dabarnard@live.com.
Elvis M IrusenDivisions of Pulmonology, Department of Medicine, Stellenbosch University, PO Box 19063, 7505, Cape Town, South Africa. eirusen@sun.ac.za.
Johannes W BruwerDivisions of Pulmonology, Department of Medicine, Stellenbosch University, PO Box 19063, 7505, Cape Town, South Africa. cdchar@sun.ac.za.
Danté PlekkerKuils River Hospital, Cape Town, South Africa. dp.krrc@mwebbiz.co.za.
Andrew C WhitelawTygerberg Academic Hospital, Cape Town, South Africa. awhitelaw@sun.ac.za.
Jacobus D DeetlefsAmpath Laboratories, Cape Town, South Africa. deetlefsj@ampath.co.za.
Coenraad F N KoegelenbergDivisions of Pulmonology, Department of Medicine, Stellenbosch University, PO Box 19063, 7505, Cape Town, South Africa. coeniefn@sun.ac.za.
Stellenbosch University · ZATygerberg Hospital · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundXpert MTB/RIF has been shown to have a superior sensitivity to microscopy for acid fast bacilli (AFB) in sputum and has been recommended as a standard first line investigation for pulmonary tuberculosis (PTB). Bronchoscopy is a valuable tool in diagnosing PTB in sputum negative patients. There is limited data on the utility of Xpert MTB/RIF performed on bronchial lavage specimens. Our aim was to evaluate the diagnostic efficiency of Xpert MTB/RIF performed on bronchial washings in sputum scarce/negative patients with suspected PTB.

methodsAll patients with a clinical and radiological suspicion of PTB who underwent bronchoscopy between January 2013 and April 2014 were included. The diagnostic efficiencies of Xpert MTB/RIF and microscopy for AFB were compared to culture for Mycobacterium tuberculosis.

resultsThirty nine of 112 patients were diagnosed with culture-positive PTB. Xpert MTB/RIF was positive in 36/39 with a sensitivity of 92.3% (95% CI 78-98%) for PTB, which was superior to that of smear microscopy (41%; 95% CI 26.0-57.8%, p = 0.005). The specificities of Xpert MTB/RIF and smear microscopy were 87.7% (95% CI 77.4-93.9%) and 98.6% (95% CI 91.6%-99.9%) respectively. Xpert MTB/RIF had a positive predictive value of 80% (95% CI; 65-89.9%) and negative predictive value of 95.5% (95% CI 86.6-98.8%). 3/9 patients with Xpert MTB/RIF positive culture negative results were treated for PTB based on clinical and radiological findings.

conclusionXpert MTB/RIF has a higher sensitivity than smear microscopy and similar specificity for the immediate confirmation of PTB in specimens obtained by bronchial washing, and should be utilised in patients with a high suspicion of pulmonary tuberculosis.

Indexed as

Early DiagnosisAdultAutomation, LaboratoryBronchoalveolar Lavage FluidBronchoscopyFemaleHumansMaleMicroscopyMiddle AgedMycobacterium tuberculosisRetrospective StudiesSensitivity and SpecificitySouth AfricaSputumTertiary Care Centers

Identifiers

PMID26377395
PMCPMC4573925
OpenAlexW2150326742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.